| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |